Fisher Asset Management LLC Sells 848,083 Shares of Sanofi (NASDAQ:SNY)

Fisher Asset Management LLC decreased its holdings in shares of Sanofi (NASDAQ:SNY - Free Report) by 6.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 12,511,027 shares of the company's stock after selling 848,083 shares during the quarter. Fisher Asset Management LLC owned about 0.49% of Sanofi worth $603,407,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Synergy Asset Management LLC bought a new stake in shares of Sanofi in the fourth quarter valued at approximately $25,000. McClarren Financial Advisors Inc. raised its stake in Sanofi by 952.6% during the 4th quarter. McClarren Financial Advisors Inc. now owns 600 shares of the company's stock valued at $28,000 after purchasing an additional 543 shares during the last quarter. Sunbelt Securities Inc. boosted its holdings in Sanofi by 72.1% in the 3rd quarter. Sunbelt Securities Inc. now owns 747 shares of the company's stock valued at $43,000 after purchasing an additional 313 shares during the period. Sierra Ocean LLC acquired a new stake in Sanofi in the 4th quarter worth $44,000. Finally, Versant Capital Management Inc bought a new position in shares of Sanofi during the 4th quarter worth about $54,000. Institutional investors and hedge funds own 14.04% of the company's stock.

Sanofi Price Performance

NASDAQ SNY traded up $2.24 on Monday, reaching $56.71. The company's stock had a trading volume of 3,080,834 shares, compared to its average volume of 2,404,660. Sanofi has a 52 week low of $45.22 and a 52 week high of $58.97. The company has a current ratio of 1.46, a quick ratio of 1.14 and a debt-to-equity ratio of 0.15. The firm has a market cap of $143.93 billion, a PE ratio of 22.77, a price-to-earnings-growth ratio of 1.01 and a beta of 0.57. The business has a 50-day moving average price of $51.65 and a 200 day moving average price of $52.59.

Sanofi (NASDAQ:SNY - Get Free Report) last released its quarterly earnings data on Thursday, January 30th. The company reported $0.70 earnings per share for the quarter, meeting the consensus estimate of $0.70. Sanofi had a return on equity of 25.61% and a net margin of 12.77%. Sell-side analysts expect that Sanofi will post 4.36 EPS for the current year.

Analyst Upgrades and Downgrades

SNY has been the topic of a number of recent research reports. Deutsche Bank Aktiengesellschaft raised Sanofi from a "sell" rating to a "hold" rating in a research report on Thursday, January 30th. StockNews.com lowered Sanofi from a "buy" rating to a "hold" rating in a report on Thursday, December 12th. Finally, Sanford C. Bernstein upgraded Sanofi to a "strong-buy" rating in a research note on Thursday, January 30th. Two equities research analysts have rated the stock with a hold rating, one has given a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Buy" and a consensus price target of $60.00.

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.